← The Wire
TECHNasdaq
BIO-TECHNE Corp
Biological Products, (No Diagnostic Substances) · MN · CIK 842023
Develops, manufactures, and sells life science reagents, instruments, and services for research, diagnostics, and bioprocessing markets
red 8-K · 90d🔥 High media attention
$8.45B
Market cap
$70.90
Last close
-0.1%
1D
+27.5%
5D
14.9M
Volume
Price · last 39 sessions+29.5%
May 4L $43.30 · H $71.00Jun 29
287
Total filings
Jun 26, 2026
Last filing
06/30
Fiscal year end
8-K/AAcquisition / DispositionOct 14, 20168-K/AAcquisition / DispositionOct 16, 20148-K/AExecutive ChangeDec 4, 20128-K/AAcquisition / DispositionJul 8, 2011
Insider Activity
In the 90 days to Feb 17, 2026: 1 sold $117K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Herr Amy E.Director | Sell | 1,976 | $59.11 | $117K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 18 reputable articles.
MorningstarBio-Techne: Merck KGaA Agrees to Acquire Bio-Techne4d agoMorningstarBio-Techne to Be Acquired by Merck KGaA4d agoInvestor's Business DailyGermany's Merck KGaA Swoops In With $11.3 Billion Medtech Buyout4d agoMarketWatchBio-Techne Corp. stock outperforms competitors on strong trading day4d agoBarron'sBio-Techne Is Today’s Top S&P 500 Stock. Germany’s Merck to Buy Company for $11.3 Billion.4d agoWSJGermany’s Merck to Boost Lab-Tools Business With $11 Billion Bio-Techne Deal4d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance